News
HAE
122.36
+3.51%
4.15
Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), Enovis (ENOV) and Haemonetics (HAE)
TipRanks · 23h ago
Weekly Report: what happened at HAE last week (1102-1106)?
Weekly Report · 2d ago
Will Raised Revenue Guidance Change Haemonetics Stock Narrative
Simply Wall St · 3d ago
Bank of America Securities Reaffirms Their Buy Rating on Haemonetics (HAE)
TipRanks · 4d ago
Haemonetics Is Maintained at Buy by Citigroup
Dow Jones · 4d ago
Haemonetics Price Target Raised to $149.00/Share From $123.00 by Citigroup
Dow Jones · 4d ago
Citigroup Maintains Buy on Haemonetics, Raises Price Target to $149
Benzinga · 4d ago
Haemonetics Price Target Raised to $145.00/Share From $140.00 by Barrington Research
Dow Jones · 4d ago
Haemonetics Is Maintained at Outperform by Barrington Research
Dow Jones · 4d ago
Barrington Research Maintains Outperform on Haemonetics, Raises Price Target to $145
Benzinga · 4d ago
Haemonetics (HAE) Lifted Guidance, Is The Stock Fully Valued?
Simply Wall St · 4d ago
Haemonetics participates in a conference call with JPMorgan
TipRanks · 4d ago
Haemonetics’ Strong Execution and CSL Plasma Upside Support Higher $142 Price Target
TipRanks · 4d ago
Haemonetics price target raised to $145 from $140 at Barrington
TipRanks · 4d ago
Haemonetics price target raised to $165 from $142 at Baird
TipRanks · 4d ago
Haemonetics Earnings Call Highlights Growth and Margin Tradeoffs
TipRanks · 5d ago
Haemonetics management to meet with Barrington
TipRanks · 5d ago
Haemonetics Is Maintained at Buy by BTIG
Dow Jones · 5d ago
Haemonetics Price Target Raised to $142.00/Share From $130.00 by BTIG
Dow Jones · 5d ago
BTIG Maintains Buy on Haemonetics, Raises Price Target to $142
Benzinga · 5d ago
More
Webull provides a variety of real-time HAE stock news. You can receive the latest news about Haemonetics Corp Mass through multiple platforms. This information may help you make smarter investment decisions.
About HAE
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.